IQVIA Stock Rises 1.11% Ahead of Q1 Earnings

IQVIA's stock price rose by 1.11% in pre-market trading on May 6, 2025, ahead of its first-quarter earnings report.

IQVIA, a leading clinical research company, is set to release its first-quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. Investors are eagerly awaiting the earnings report, which is expected to provide insights into the company's performance and future outlook. The earnings call is scheduled for 8:00 a.m. - 9:00 a.m. ET on the same day, allowing analysts and investors to discuss the financial results in detail.

Prior to the earnings release, Jefferies adjusted its price target for IQVIA, reflecting the market's anticipation of the company's performance. The adjustment comes as part of the broader market sentiment, which has been influenced by various factors, including trade policy uncertainty and the performance of other major companies.